Request for Covid-19 Impact Assessment of this Report
The United States Typhoid Fever Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Typhoid Fever Vaccines market, reaching US$ million by the year 2028. As for the Europe Typhoid Fever Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Typhoid Fever Vaccines players cover Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, and PaxVax, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Typhoid Fever Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Live Attenuated Vaccine
Conjugate Vaccine
Capsular Polysaccharide Vaccines
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Government Institution
Private Sector
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi Pasteur
GlaxoSmithKline
Bharat Biotech
PaxVax
Biomed
Prokarium
China National Biotec Group
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Typhoid Fever Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Typhoid Fever Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Typhoid Fever Vaccines by Country/Region, 2017, 2022 & 2028
2.2 Typhoid Fever Vaccines Segment by Type
2.2.1 Live Attenuated Vaccine
2.2.2 Conjugate Vaccine
2.2.3 Capsular Polysaccharide Vaccines
2.2.4 Others
2.3 Typhoid Fever Vaccines Sales by Type
2.3.1 Global Typhoid Fever Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global Typhoid Fever Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global Typhoid Fever Vaccines Sale Price by Type (2017-2022)
2.4 Typhoid Fever Vaccines Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.5 Typhoid Fever Vaccines Sales by Application
2.5.1 Global Typhoid Fever Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global Typhoid Fever Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global Typhoid Fever Vaccines Sale Price by Application (2017-2022)
3 Global Typhoid Fever Vaccines by Company
3.1 Global Typhoid Fever Vaccines Breakdown Data by Company
3.1.1 Global Typhoid Fever Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global Typhoid Fever Vaccines Sales Market Share by Company (2020-2022)
3.2 Global Typhoid Fever Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global Typhoid Fever Vaccines Revenue by Company (2020-2022)
3.2.2 Global Typhoid Fever Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global Typhoid Fever Vaccines Sale Price by Company
3.4 Key Manufacturers Typhoid Fever Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Typhoid Fever Vaccines Product Location Distribution
3.4.2 Players Typhoid Fever Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Typhoid Fever Vaccines by Geographic Region
4.1 World Historic Typhoid Fever Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global Typhoid Fever Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Typhoid Fever Vaccines Annual Revenue by Geographic Region
4.2 World Historic Typhoid Fever Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global Typhoid Fever Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global Typhoid Fever Vaccines Annual Revenue by Country/Region
4.3 Americas Typhoid Fever Vaccines Sales Growth
4.4 APAC Typhoid Fever Vaccines Sales Growth
4.5 Europe Typhoid Fever Vaccines Sales Growth
4.6 Middle East & Africa Typhoid Fever Vaccines Sales Growth
5 Americas
5.1 Americas Typhoid Fever Vaccines Sales by Country
5.1.1 Americas Typhoid Fever Vaccines Sales by Country (2017-2022)
5.1.2 Americas Typhoid Fever Vaccines Revenue by Country (2017-2022)
5.2 Americas Typhoid Fever Vaccines Sales by Type
5.3 Americas Typhoid Fever Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Typhoid Fever Vaccines Sales by Region
6.1.1 APAC Typhoid Fever Vaccines Sales by Region (2017-2022)
6.1.2 APAC Typhoid Fever Vaccines Revenue by Region (2017-2022)
6.2 APAC Typhoid Fever Vaccines Sales by Type
6.3 APAC Typhoid Fever Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Typhoid Fever Vaccines by Country
7.1.1 Europe Typhoid Fever Vaccines Sales by Country (2017-2022)
7.1.2 Europe Typhoid Fever Vaccines Revenue by Country (2017-2022)
7.2 Europe Typhoid Fever Vaccines Sales by Type
7.3 Europe Typhoid Fever Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Typhoid Fever Vaccines by Country
8.1.1 Middle East & Africa Typhoid Fever Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa Typhoid Fever Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa Typhoid Fever Vaccines Sales by Type
8.3 Middle East & Africa Typhoid Fever Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Typhoid Fever Vaccines
10.3 Manufacturing Process Analysis of Typhoid Fever Vaccines
10.4 Industry Chain Structure of Typhoid Fever Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Typhoid Fever Vaccines Distributors
11.3 Typhoid Fever Vaccines Customer
12 World Forecast Review for Typhoid Fever Vaccines by Geographic Region
12.1 Global Typhoid Fever Vaccines Market Size Forecast by Region
12.1.1 Global Typhoid Fever Vaccines Forecast by Region (2023-2028)
12.1.2 Global Typhoid Fever Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Typhoid Fever Vaccines Forecast by Type
12.7 Global Typhoid Fever Vaccines Forecast by Application
13 Key Players Analysis
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Typhoid Fever Vaccines Product Offered
13.1.3 Sanofi Pasteur Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Information
13.2.2 GlaxoSmithKline Typhoid Fever Vaccines Product Offered
13.2.3 GlaxoSmithKline Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GlaxoSmithKline Main Business Overview
13.2.5 GlaxoSmithKline Latest Developments
13.3 Bharat Biotech
13.3.1 Bharat Biotech Company Information
13.3.2 Bharat Biotech Typhoid Fever Vaccines Product Offered
13.3.3 Bharat Biotech Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bharat Biotech Main Business Overview
13.3.5 Bharat Biotech Latest Developments
13.4 PaxVax
13.4.1 PaxVax Company Information
13.4.2 PaxVax Typhoid Fever Vaccines Product Offered
13.4.3 PaxVax Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 PaxVax Main Business Overview
13.4.5 PaxVax Latest Developments
13.5 Biomed
13.5.1 Biomed Company Information
13.5.2 Biomed Typhoid Fever Vaccines Product Offered
13.5.3 Biomed Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Biomed Main Business Overview
13.5.5 Biomed Latest Developments
13.6 Prokarium
13.6.1 Prokarium Company Information
13.6.2 Prokarium Typhoid Fever Vaccines Product Offered
13.6.3 Prokarium Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Prokarium Main Business Overview
13.6.5 Prokarium Latest Developments
13.7 China National Biotec Group
13.7.1 China National Biotec Group Company Information
13.7.2 China National Biotec Group Typhoid Fever Vaccines Product Offered
13.7.3 China National Biotec Group Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 China National Biotec Group Main Business Overview
13.7.5 China National Biotec Group Latest Developments
14 Research Findings and Conclusion
Table 1. Typhoid Fever Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Typhoid Fever Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Live Attenuated Vaccine
Table 4. Major Players of Conjugate Vaccine
Table 5. Major Players of Capsular Polysaccharide Vaccines
Table 6. Major Players of Others
Table 7. Global Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)
Table 8. Global Typhoid Fever Vaccines Sales Market Share by Type (2017-2022)
Table 9. Global Typhoid Fever Vaccines Revenue by Type (2017-2022) & ($ million)
Table 10. Global Typhoid Fever Vaccines Revenue Market Share by Type (2017-2022)
Table 11. Global Typhoid Fever Vaccines Sale Price by Type (2017-2022) & (USD/Dose)
Table 12. Global Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)
Table 13. Global Typhoid Fever Vaccines Sales Market Share by Application (2017-2022)
Table 14. Global Typhoid Fever Vaccines Revenue by Application (2017-2022)
Table 15. Global Typhoid Fever Vaccines Revenue Market Share by Application (2017-2022)
Table 16. Global Typhoid Fever Vaccines Sale Price by Application (2017-2022) & (USD/Dose)
Table 17. Global Typhoid Fever Vaccines Sales by Company (2020-2022) & (K Doses)
Table 18. Global Typhoid Fever Vaccines Sales Market Share by Company (2020-2022)
Table 19. Global Typhoid Fever Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Typhoid Fever Vaccines Revenue Market Share by Company (2020-2022)
Table 21. Global Typhoid Fever Vaccines Sale Price by Company (2020-2022) & (USD/Dose)
Table 22. Key Manufacturers Typhoid Fever Vaccines Producing Area Distribution and Sales Area
Table 23. Players Typhoid Fever Vaccines Products Offered
Table 24. Typhoid Fever Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Typhoid Fever Vaccines Sales by Geographic Region (2017-2022) & (K Doses)
Table 28. Global Typhoid Fever Vaccines Sales Market Share Geographic Region (2017-2022)
Table 29. Global Typhoid Fever Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Typhoid Fever Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Typhoid Fever Vaccines Sales by Country/Region (2017-2022) & (K Doses)
Table 32. Global Typhoid Fever Vaccines Sales Market Share by Country/Region (2017-2022)
Table 33. Global Typhoid Fever Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Typhoid Fever Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Typhoid Fever Vaccines Sales by Country (2017-2022) & (K Doses)
Table 36. Americas Typhoid Fever Vaccines Sales Market Share by Country (2017-2022)
Table 37. Americas Typhoid Fever Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Typhoid Fever Vaccines Revenue Market Share by Country (2017-2022)
Table 39. Americas Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)
Table 40. Americas Typhoid Fever Vaccines Sales Market Share by Type (2017-2022)
Table 41. Americas Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)
Table 42. Americas Typhoid Fever Vaccines Sales Market Share by Application (2017-2022)
Table 43. APAC Typhoid Fever Vaccines Sales by Region (2017-2022) & (K Doses)
Table 44. APAC Typhoid Fever Vaccines Sales Market Share by Region (2017-2022)
Table 45. APAC Typhoid Fever Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Typhoid Fever Vaccines Revenue Market Share by Region (2017-2022)
Table 47. APAC Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)
Table 48. APAC Typhoid Fever Vaccines Sales Market Share by Type (2017-2022)
Table 49. APAC Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)
Table 50. APAC Typhoid Fever Vaccines Sales Market Share by Application (2017-2022)
Table 51. Europe Typhoid Fever Vaccines Sales by Country (2017-2022) & (K Doses)
Table 52. Europe Typhoid Fever Vaccines Sales Market Share by Country (2017-2022)
Table 53. Europe Typhoid Fever Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Typhoid Fever Vaccines Revenue Market Share by Country (2017-2022)
Table 55. Europe Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)
Table 56. Europe Typhoid Fever Vaccines Sales Market Share by Type (2017-2022)
Table 57. Europe Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)
Table 58. Europe Typhoid Fever Vaccines Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Typhoid Fever Vaccines Sales by Country (2017-2022) & (K Doses)
Table 60. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Typhoid Fever Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Typhoid Fever Vaccines Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)
Table 64. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)
Table 66. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Typhoid Fever Vaccines
Table 68. Key Market Challenges & Risks of Typhoid Fever Vaccines
Table 69. Key Industry Trends of Typhoid Fever Vaccines
Table 70. Typhoid Fever Vaccines Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Typhoid Fever Vaccines Distributors List
Table 73. Typhoid Fever Vaccines Customer List
Table 74. Global Typhoid Fever Vaccines Sales Forecast by Region (2023-2028) & (K Doses)
Table 75. Global Typhoid Fever Vaccines Sales Market Forecast by Region
Table 76. Global Typhoid Fever Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Typhoid Fever Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Typhoid Fever Vaccines Sales Forecast by Country (2023-2028) & (K Doses)
Table 79. Americas Typhoid Fever Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Typhoid Fever Vaccines Sales Forecast by Region (2023-2028) & (K Doses)
Table 81. APAC Typhoid Fever Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Typhoid Fever Vaccines Sales Forecast by Country (2023-2028) & (K Doses)
Table 83. Europe Typhoid Fever Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Typhoid Fever Vaccines Sales Forecast by Country (2023-2028) & (K Doses)
Table 85. Middle East & Africa Typhoid Fever Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Typhoid Fever Vaccines Sales Forecast by Type (2023-2028) & (K Doses)
Table 87. Global Typhoid Fever Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Typhoid Fever Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Typhoid Fever Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Typhoid Fever Vaccines Sales Forecast by Application (2023-2028) & (K Doses)
Table 91. Global Typhoid Fever Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Typhoid Fever Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Typhoid Fever Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 94. Sanofi Pasteur Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. Sanofi Pasteur Typhoid Fever Vaccines Product Offered
Table 96. Sanofi Pasteur Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 97. Sanofi Pasteur Main Business
Table 98. Sanofi Pasteur Latest Developments
Table 99. GlaxoSmithKline Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. GlaxoSmithKline Typhoid Fever Vaccines Product Offered
Table 101. GlaxoSmithKline Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 102. GlaxoSmithKline Main Business
Table 103. GlaxoSmithKline Latest Developments
Table 104. Bharat Biotech Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Bharat Biotech Typhoid Fever Vaccines Product Offered
Table 106. Bharat Biotech Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 107. Bharat Biotech Main Business
Table 108. Bharat Biotech Latest Developments
Table 109. PaxVax Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. PaxVax Typhoid Fever Vaccines Product Offered
Table 111. PaxVax Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 112. PaxVax Main Business
Table 113. PaxVax Latest Developments
Table 114. Biomed Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 115. Biomed Typhoid Fever Vaccines Product Offered
Table 116. Biomed Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 117. Biomed Main Business
Table 118. Biomed Latest Developments
Table 119. Prokarium Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 120. Prokarium Typhoid Fever Vaccines Product Offered
Table 121. Prokarium Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 122. Prokarium Main Business
Table 123. Prokarium Latest Developments
Table 124. China National Biotec Group Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 125. China National Biotec Group Typhoid Fever Vaccines Product Offered
Table 126. China National Biotec Group Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 127. China National Biotec Group Main Business
Table 128. China National Biotec Group Latest Developments
List of Figures
Figure 1. Picture of Typhoid Fever Vaccines
Figure 2. Typhoid Fever Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Typhoid Fever Vaccines Sales Growth Rate 2017-2028 (K Doses)
Figure 7. Global Typhoid Fever Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Typhoid Fever Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Live Attenuated Vaccine
Figure 10. Product Picture of Conjugate Vaccine
Figure 11. Product Picture of Capsular Polysaccharide Vaccines
Figure 12. Product Picture of Others
Figure 13. Global Typhoid Fever Vaccines Sales Market Share by Type in 2021
Figure 14. Global Typhoid Fever Vaccines Revenue Market Share by Type (2017-2022)
Figure 15. Typhoid Fever Vaccines Consumed in Government Institution
Figure 16. Global Typhoid Fever Vaccines Market: Government Institution (2017-2022) & (K Doses)
Figure 17. Typhoid Fever Vaccines Consumed in Private Sector
Figure 18. Global Typhoid Fever Vaccines Market: Private Sector (2017-2022) & (K Doses)
Figure 19. Global Typhoid Fever Vaccines Sales Market Share by Application (2017-2022)
Figure 20. Global Typhoid Fever Vaccines Revenue Market Share by Application in 2021
Figure 21. Typhoid Fever Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Typhoid Fever Vaccines Revenue Market Share by Company in 2021
Figure 23. Global Typhoid Fever Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Typhoid Fever Vaccines Revenue Market Share by Geographic Region in 2021
Figure 25. Global Typhoid Fever Vaccines Sales Market Share by Region (2017-2022)
Figure 26. Global Typhoid Fever Vaccines Revenue Market Share by Country/Region in 2021
Figure 27. Americas Typhoid Fever Vaccines Sales 2017-2022 (K Doses)
Figure 28. Americas Typhoid Fever Vaccines Revenue 2017-2022 ($ Millions)
Figure 29. APAC Typhoid Fever Vaccines Sales 2017-2022 (K Doses)
Figure 30. APAC Typhoid Fever Vaccines Revenue 2017-2022 ($ Millions)
Figure 31. Europe Typhoid Fever Vaccines Sales 2017-2022 (K Doses)
Figure 32. Europe Typhoid Fever Vaccines Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Typhoid Fever Vaccines Sales 2017-2022 (K Doses)
Figure 34. Middle East & Africa Typhoid Fever Vaccines Revenue 2017-2022 ($ Millions)
Figure 35. Americas Typhoid Fever Vaccines Sales Market Share by Country in 2021
Figure 36. Americas Typhoid Fever Vaccines Revenue Market Share by Country in 2021
Figure 37. United States Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Typhoid Fever Vaccines Sales Market Share by Region in 2021
Figure 42. APAC Typhoid Fever Vaccines Revenue Market Share by Regions in 2021
Figure 43. China Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Typhoid Fever Vaccines Sales Market Share by Country in 2021
Figure 50. Europe Typhoid Fever Vaccines Revenue Market Share by Country in 2021
Figure 51. Germany Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Typhoid Fever Vaccines Revenue Market Share by Country in 2021
Figure 58. Egypt Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Typhoid Fever Vaccines in 2021
Figure 64. Manufacturing Process Analysis of Typhoid Fever Vaccines
Figure 65. Industry Chain Structure of Typhoid Fever Vaccines
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...